United States· US:40032-090_dd003952-2ae1-4c8d-9f2e-8dd6ae470279
POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES
A medicinal product containing polyethylene glycol 3350; sodium sulfate anhydrous; sodium bicarbonate; sodium chloride; potassium chloride, registered in United States by Novel Laboratories, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- POLYETHYLENE GLYCOL 3350; SODIUM SULFATE ANHYDROUS; SODIUM BICARBONATE; SODIUM CHLORIDE; POTASSIUM CHLORIDE
- Manufacturer
- Novel Laboratories, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc114003209019274.31 g in 1 BOTTLE (40032-090-19)
- ndc1140032-090-19
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Polyethylene glycol 3350; sodium sulfate anhydrous; sodium bicarbonate; sodium chloride; potassium chloride in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandMacrogol Fairmed Junior, PulverStrides Pharma International AG
- GermanyColosolDr. Falk Pharma G.M.B.H.
- FinlandDuphagolCooper Consumer Health B.V.
- IrelandLaxido Orange, powder for oral solutionGalen Pharma Ireland Limited
- SwedenAbdomin Citrus Pulver till oral lösning i dospåseOrifarm Healthcare A/S
- NorwayLaxirivaSandoz A/S
- NetherlandsBENLAXID 13,7 g poeder voor drankItalfarmaco, S.A.
- IcelandMovicolNorgine Healthcare B.V.
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Endofalk, Laxogol
- Belgium · Curapeg, Laxido Junior Neutral
- Bulgaria · Ендофалк
- Cyprus · Molaxole
- Germany · Colosol, Endofalk Classic
- Denmark · Abdomin Citrus, Abdomin Junior Neutral
- Spain · Acolora, Atolaxant
- Finland · Duphagol, Duphagol Junior
- France · Macrogol 3350 Norgine Enfants, Movicol
- United Kingdom (Northern Ireland) · Compound Macrogol, Compound Macrogol Manx Healthcare
- Greece · Bimotil, Clinitrat
- Ireland · Laxido, Laxido Orange
- Iceland · Movicol, Movicol Junior Neutral
- Italy · Benlaxid, Goganza
- Luxembourg · Laxido Junior Neutral, Laxido Nature
- Malta · Macrolief, Movicol
- Netherlands · Benlaxid, Macrogol En Electrolyten Ratiopharm
- Norway · Abdomin Junior Med Nøytral Smak, Abdomin Med Nøytral Smak
- Poland · Aurogo
- Portugal · Duphagol, Endofalk
- Sweden · Abdomin Citrus, Abdomin Junior Neutral
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a89878df-2f4c-49b3-93a2-c5bf9c5e840c GET /v1/drugs/a89878df-2f4c-49b3-93a2-c5bf9c5e840c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "236; 22.74; 6.74; 5.86; 2.97",
"substance": "POLYETHYLENE GLYCOL 3350; SODIUM SULFATE ANHYDROUS; SODIUM BICARBONATE; SODIUM CHLORIDE; POTASSIUM CHLORIDE",
"productndc": "40032-090",
"dosage_form": "POWDER, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "g/274.31g; g/274.31g; g/274.31g; g/274.31g; g/274.31g",
"application_number": "ANDA090231",
"marketing_category": "ANDA"
}See everything about polyethylene glycol 3350; sodium sulfate anhydrous; sodium bicarbonate; sodium chloride; potassium chloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.